Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma

F Petersson, P Grossmann, M Hora, M Sperga, DP Montiel, P Martinek, ME Gutierrez, S Bulimbasic, M Michal, J Branzovsky, O Hes

. 2013 ; 44 (7) : 1412-1420.

Language English Country United States

Grant support
NT12010 MZ0 CEP Register

We present a cohort of 8 renal carcinomas that displayed a variable (5%-95% extent) light microscopic appearance of renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma (RAT/CCPRCC) without fulfilling the criteria for these tumors. All but 1 case predominantly (75%-95% extent) showed histopathologic features of conventional clear cell renal cell carcinoma. In 5 of 7 cases with mostly conventional clear renal cell carcinoma (CRCC) morphology, a diagnosis of CRCC was supported by the molecular genetic findings (presence of von Hippel-Lindau tumor suppressor [VHL] mutation and/or VHL promoter methylation and/or loss of heterozygosity [LOH] for 3p). Of the other 2 cases with predominantly characteristic CRCC morphology, 1 tumor did not reveal any VHL mutation, VHL promoter methylation, or LOH for 3p, and both chromosomes 7 and 17 were disomic, whereas the other tumor displayed polysomy for chromosomes 7 and 17 and no VHL mutation, VHL promoter methylation, or LOH for 3p. One tumor was composed primarily (95%) of distinctly RAT/CCPRCC-like morphology, and this tumor harbored a VHL mutation and displayed polysomy for chromosomes 7 and 17. Of the 5 cases with both histomorphologic features and molecular genetic findings of CRCC, we detected significant immunoreactivity for alpha-methylacyl-CoA racemase in 2 cases and strong diffuse immunopositivity for cytokeratin 7 in 3 cases. Despite the combination of positivity for alpha-methylacyl-CoA racemase and cytokeratin 7 in 2 cases, there was nothing to suggest of the possibility of a conventional papillary renal cell carcinoma with a predominance of clear cells.Copyright © 2013 Elsevier Inc. All rights reserved.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18038392
003      
CZ-PrNML
005      
20241120102823.0
007      
ta
008      
181121s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.humpath.2012.11.019 $2 doi
035    __
$a (PubMed)23434146
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Petersson, Fredrik $u Petersson, Fredrik. Department of Pathology, National University Health System, Singapore, Singapore.
245    10
$a Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma / $c F Petersson, P Grossmann, M Hora, M Sperga, DP Montiel, P Martinek, ME Gutierrez, S Bulimbasic, M Michal, J Branzovsky, O Hes
520    9_
$a We present a cohort of 8 renal carcinomas that displayed a variable (5%-95% extent) light microscopic appearance of renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma (RAT/CCPRCC) without fulfilling the criteria for these tumors. All but 1 case predominantly (75%-95% extent) showed histopathologic features of conventional clear cell renal cell carcinoma. In 5 of 7 cases with mostly conventional clear renal cell carcinoma (CRCC) morphology, a diagnosis of CRCC was supported by the molecular genetic findings (presence of von Hippel-Lindau tumor suppressor [VHL] mutation and/or VHL promoter methylation and/or loss of heterozygosity [LOH] for 3p). Of the other 2 cases with predominantly characteristic CRCC morphology, 1 tumor did not reveal any VHL mutation, VHL promoter methylation, or LOH for 3p, and both chromosomes 7 and 17 were disomic, whereas the other tumor displayed polysomy for chromosomes 7 and 17 and no VHL mutation, VHL promoter methylation, or LOH for 3p. One tumor was composed primarily (95%) of distinctly RAT/CCPRCC-like morphology, and this tumor harbored a VHL mutation and displayed polysomy for chromosomes 7 and 17. Of the 5 cases with both histomorphologic features and molecular genetic findings of CRCC, we detected significant immunoreactivity for alpha-methylacyl-CoA racemase in 2 cases and strong diffuse immunopositivity for cytokeratin 7 in 3 cases. Despite the combination of positivity for alpha-methylacyl-CoA racemase and cytokeratin 7 in 2 cases, there was nothing to suggest of the possibility of a conventional papillary renal cell carcinoma with a predominance of clear cells.<ovid:br /><ovid:br />Copyright &#xa9; 2013 Elsevier Inc. All rights reserved.
590    __
$a bohemika - dle Pubmed
650    12
$a adenom $x diagnostické zobrazování $7 D000236
650    02
$a dospělí $7 D000328
650    02
$a senioři $7 D000368
650    12
$a angiomyom $x diagnóza $7 D018229
650    12
$a papilární karcinom $x diagnóza $7 D002291
650    12
$a karcinom z renálních buněk $x diagnóza $7 D002292
650    02
$a chromozomální aberace $7 D002869
650    02
$a lidské chromozomy, pár 17 $7 D002886
650    02
$a lidské chromozomy, pár 7 $7 D002897
650    02
$a diferenciální diagnóza $7 D003937
650    02
$a ženské pohlaví $7 D005260
650    02
$a keratin-7 $x metabolismus $7 D053552
650    12
$a nádory ledvin $x diagnóza $7 D007680
650    02
$a ztráta heterozygozity $7 D019656
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
650    02
$a mutace $7 D009154
650    02
$a mnohočetné primární nádory $x diagnóza $7 D009378
650    02
$a racemasy a epimerasy $x metabolismus $7 D019998
650    02
$a nádorový supresorový protein VHL $x genetika $7 D051794
650    02
$a von Hippelova-Lindauova nemoc $7 D006623
650    _2
$a lidé $7 D006801
700    1_
$a Grossmann, Petr $7 xx0108998
700    1_
$a Hora, Milan, $d 1967- $7 mzk2004258359
700    1_
$a Sperga, M
700    1_
$a Montiel DP
700    1_
$a Martínek, Petr $7 xx0243624
700    1_
$a Gutierrez ME
700    1_
$a Bulimbasic S
700    1_
$a Michal, Michal, $d 1959- $7 jn20001103501
700    1_
$a Branžovský, Jindřich, $d 1987- $7 xx0324720
700    1_
$a Hes, Ondřej, $d 1968- $7 jn20001103502
773    0_
$t Human Pathology $g Roč. 44, č. 7 (2013), s. 1412-1420 $p Hum Pathol $x 0046-8177 $w MED00002080
773    0_
$p Hum Pathol $g 44(7):1412-20, 2013 Jul
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20181121142553 $b ABA008
991    __
$a 20241120102818 $b ABA008
999    __
$a ok $b bmc $g 1352927 $s 1035431
BAS    __
$a 3
BMC    __
$a 2013 $b 44 $c 7 $d 1412-1420 $x MED00002080 $i 0046-8177 $m Human pathology
GRA    __
$a NT12010 $p MZ0
LZP    __
$a NLK 2018/lp

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...